Around the beginning of May 2018 Delphi Medical were made aware of the potential risk of cost increases in buprenorphine secondary to the implementation of a central pricing control mechanism. The most important issue from a Delphi Medical point of view is to ensure that our patients receiving buprenorphine have continuity of care as part … Continued
The Calico Group is pleased to announce that Delphi Medical has secured new premises in Lancaster for its Pavilion service.
Leading independent provider of drug and alcohol treatment services, Delphi Medical, has officially become part of The Calico Group.
The lifesaving drug naloxone is now available to residents of supported housing services in Sefton.
From the 1st September 2014, Delphi Medical will be partnering with local health service provider FCMS to deliver the clinical element of the Horizon treatment system in Blackpool, ensuring safe, accessible and effective prescribed treatment for patients with drug and alcohol misuse.
Delphi Medical has teamed up with Patients Know Best to become the first provider of substance misuse services in the UK to put patients in control of their own medical records.
Delphi has achieved a new milestone after the award of its ‘eleventh’ contract to provide prison-based addiction recovery services at HMP Kennett, a Category C Prison near Liverpool.
Delphi Medical are working in partnership with Lifeline to deliver the Sefton Treatment and Recovery Service (STARS); a fully integrated substance misuse service for adults with drug and/or alcohol problems living in Sefton Borough.
Lancaster-based Delphi Medical has achieved a new milestone after announcing the award of its tenth contract to provide prison-based addiction recovery services.
Delphi Medical has been awarded new prison contracts to work with Staffordshire Prisons and Buckley Hall Prison in Rochdale to provide drug and alcohol treatment services.